Orlistat丨CAS 96829-58-2

Orlistat丨CAS 96829-58-2
Product Introduction:
Catalog No.: SS130569
CAS No.: 96829-58-2
Assay: 98% min (on anhydrous)
Product Name: Orlistat
Molecular Formula: C29H53NO5
Molecular Weight: 495.73
Synonym(s): Orlipastat
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of orlistat丨cas 96829-58-2 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance White or almost white crystalline powder
Assay 98% min (on anhydrous)
Specific rotation -48° ~ -51°
Identification HPLC/IR Complies
Solution Very soluble in methanol and ethanol, freely soluble in chloroform, practically insoluble in water
Melting point 42 ~ 46°C
Any other single impurity 1.0% max
Total impurities 2.0% max
Methanol 3000 ppm max
Ethanol 5000 ppm max
Acetonitrile 410 ppm max
Heptane 5000 ppm max
Water 0.5% max
Pd 5 ppm max
Residue on ignition 0.1% max
Heavy metals 20 ppm max
Total aerobic count 900 CFU/g max
Moulds and yeasts 90 CFU/g max
Escherichia coli Negative

 

 

 

Applications

 

Orlistat (CAS 96829-58-2) is a well-known pharmaceutical compound primarily used as an anti-obesity drug. Its main application is in the treatment and management of obesity, often prescribed alongside a reduced-calorie diet and lifestyle modifications. Orlistat works locally in the gastrointestinal tract by inhibiting gastric and pancreatic lipases, the enzymes responsible for breaking down dietary fats into absorbable free fatty acids and monoglycerides. As a result, approximately 30% of ingested fat is not absorbed and is instead excreted, reducing overall calorie intake. It is commonly formulated in capsule form for clinical use and is approved in many countries for long-term weight management. Beyond obesity, Orlistat is sometimes applied off-label in conditions where reduced fat absorption may be beneficial, such as certain metabolic disorders.

 

Benefits

 

The benefits of Orlistat are strongly associated with its mechanism of action and clinical outcomes. It provides a non-systemic approach to weight management, as it acts locally in the digestive system without significant systemic absorption, reducing the risk of systemic side effects. By lowering fat absorption, it helps patients achieve meaningful weight loss when combined with dietary changes, which in turn reduces risk factors associated with obesity, such as hypertension, type 2 diabetes, dyslipidemia, and cardiovascular disease. Orlistat also supports improved glycemic control in overweight or obese patients with type 2 diabetes, contributing to better overall metabolic health. Its long-term use, when medically supervised, can help patients sustain weight reduction, improve quality of life, and reduce obesity-related health complications.

 

Conclusion

 

In conclusion, Orlistat is an effective pharmaceutical agent for managing obesity and supporting weight-related health improvements. Its localized mechanism of action, ability to aid in clinically significant weight loss, and positive effects on obesity-related comorbidities make it a cornerstone in pharmacological weight management strategies. By complementing dietary and lifestyle interventions, Orlistat offers patients a practical and evidence-based option for achieving sustainable improvements in both body weight and overall health.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us